|
CN105348069A
|
|
Synthesis process of glibenclamide intermediate 5-chlorosalicylic acid
|
|
CN105348166A
|
|
Process for chlorinating cephalosporin intermediate GCLE
|
|
CN105085545A
|
|
Method for preparing cefdinir and regulating crystal form of cefdinir
|
|
CN105111113A
|
|
Refining method for producing glibenclamide
|
|
CN105175361A
|
|
Improved production process for repaglinide
|
|
CN105111112A
|
|
Refining process for intermediate benzsulfamide of blood glucose-reducing drug glibenclamide
|
|
CN105130868A
|
|
Improved technology for synthesis of GCLE intermediate
|
|
CN105111224A
|
|
Cefixime refining method
|
|
CN105111114A
|
|
Method for recovering benzene sulfinic acid from drug intermediate GCLE mother solution
|
|
CN105067721A
|
|
Method for measuring contents of B1, B3, and B6 in B-group vitamin tablet
|
|
CN105061469A
|
|
Free refining method of cefprozil DMF compound
|
|
CN105130925A
|
|
Preparation method of 2-(Z)-(2-aminothiazol-4-yl)-2-acetoxyiminoacetic acid-2-benzothiazolthioester
|
|
CN105111223A
|
|
Refining method of 7-APCA intermediate of cefprozil
|
|
CN104672253A
|
|
Method for reducing residual ethanol in cefdinir bulk drug
|
|
CN104672176A
|
|
Method for improving product yield of repaglinide synthesis technology
|
|
CN104672117A
|
|
Process for recovering residue from glibenclamide synthesis process
|
|
CN104672254A
|
|
Preparation method of cefdinir
|
